Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
World Journal of Gastroenterology|November 18, 2015
Zebrafish as a disease model for studying human hepatocellular carcinomaJeng-Wei Lu, Yi-Jung Ho, Yi-Ju Yang, et al.
International Journal of Molecular Sciences|March 14, 2019
Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of CabozantinibYa-Chen Ko, Chung-Yi Hu, Zheng-Hau Liu, et al.
Molecular Oncology|January 19, 2019
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinomaHui-Huang Lai, Chih-Wei Li, Chih-Chen Hong, et al.
British Journal of Cancer|March 3, 2022
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinomaYu-Yun Shao, Pai-Sheng Chen, Liang-In Lin, et al.
Life Sciences|October 17, 2024
Regorafenib enhances M1/M2 macrophage polarization by inhibiting the secretion of plasminogen activator inhibitor-1 in head and neck squamous cell carcinomaYu-Hsin Chen, Yi-Mei Lee, Da-Liang Ou, et al.
Medical Oncology (Northwood, London, England)|June 20, 2015
MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabineJeng-Wei Lu, Yu-Min Lin, Yen-Ling Lai, et al.
Journal for Immunotherapy of Cancer|February 20, 2025
Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma modelsYing-Chun Shen, Nai-Wen Chang, Ching-Ping Yeh, et al.
Biomedicines|December 24, 2021
Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome AnalysisYu-Hsuan Fu, Chi-Yang Tseng, Jeng-Wei Lu, et al.
Liver Cancer|August 20, 2021
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular CarcinomaChia-Lang Hsu, Da-Liang Ou, Li-Yuan Bai, et al.
The Journal of Pathology|January 15, 2023
SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinomaYi-Mei Lee, Yu-Hsin Chen, Da-Liang Ou, et al.
Pageof 5